Key points are not available for this paper at this time.
BACKGROUND: Colon cancer is common worldwide and is the leading cause of cancer-related death. Multiple levels of omics data are available due to the development of sequencing technologies. In this study, we proposed an integrative prognostic model for colon cancer based on the integration of clinical and multi-omics data. METHODS: In total, 344 patients were included in this study. Clinical, gene expression, DNA methylation and miRNA expression data were retrieved from The Cancer Genome Atlas (TCGA). To accommodate the high dimensionality of omics data, unsupervised clustering was used as dimension reduction method. The bias-corrected Harrell's concordance index was used to verify which clustering result provided the best prognostic performance. Finally, we proposed a prognostic prediction model based on the integration of clinical data and multi-omics data. Uno's concordance index with cross-validation was used to compare the discriminative performance of the prognostic model constructed with different covariates. RESULTS: Combinations of clinical and multi-omics data can improve prognostic performance, as shown by the increase of the bias-corrected Harrell's concordance of the prognostic model from 0.7424 (clinical features only) to 0.7604 (clinical features and three types of omics features). Additionally, 2-year, 3-year and 5-year Uno's concordance statistics increased from 0.7329, 0.7043, and 0.7002 (clinical features only) to 0.7639, 0.7474 and 0.7597 (clinical features and three types of omics features), respectively. CONCLUSION: In conclusion, this study successfully combined clinical and multi-omics data for better prediction of colon cancer prognosis.
Tong et al. (Fri,) studied this question.